Literature DB >> 14871279

Prevalence and characteristics of familial hepatocellular carcinoma caused by chronic hepatitis B infection in Hong Kong.

A O O Chan1, M F Yuen, C M Lam, C Y Fong, B C Y Wong, C L Lai.   

Abstract

BACKGROUND: Hepatitis B virus infection is an important aetiological factor for hepatocellular carcinoma. Clusters of hepatocellular carcinoma have been observed in families infected with hepatitis B virus. AIM: To investigate the prevalence and characteristics of hepatocellular carcinoma associated with familial hepatitis B virus in Hong Kong.
METHODS: Hepatitis B virus patients were screened for familial hepatocellular carcinoma using a standardized questionnaire. The clinical features of patients with familial hepatocellular carcinoma were compared with those of 118 patients with sporadic hepatocellular carcinoma attending the clinic during the same period.
RESULTS: A total of 5080 patients were interviewed. Validation of the questionnaire indicated that the reliability was high. There were 22 families with familial hepatocellular carcinoma, giving a prevalence of 4.3 families/1000 hepatitis B virus carriers. The mean age of onset was 48.5 +/- 13 years in familial hepatocellular carcinoma and 62 +/- 11 years in sporadic hepatocellular carcinoma (P = 0.005). The ages of onset were 59 +/- 11, 40 +/- 10 and 18 +/- 4 years in the first, second and third generations, respectively (P < 0.0001), suggesting an anticipation phenomenon. Familial hepatocellular carcinoma patients were more likely to present with pain (70% vs. 10%, P < 0.0001), but not on routine screening (14% vs. 52%, P < 0.0001), than sporadic hepatocellular carcinoma patients.
CONCLUSION: The prevalence of familial hepatocellular carcinoma is significant in Hong Kong. These patients show specific clinical features when compared with patients with sporadic hepatocellular carcinoma.

Entities:  

Mesh:

Year:  2004        PMID: 14871279     DOI: 10.1046/j.1365-2036.2004.01855.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  4 in total

1.  Viral hepatitis: 'Immune tolerance' in HBV infection: danger lurks.

Authors:  Wai-Kay Seto; Man-Fung Yuen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-09-14       Impact factor: 46.802

2.  The Jade Ribbon Campaign: a model program for community outreach and education to prevent liver cancer in Asian Americans.

Authors:  Stephanie D Chao; Ellen T Chang; Phuoc V Le; Wijan Prapong; Michaela Kiernan; Samuel K S So
Journal:  J Immigr Minor Health       Date:  2007-11-08

3.  Synergistic effects of family history of hepatocellular carcinoma and hepatitis B virus infection on risk for incident hepatocellular carcinoma.

Authors:  Rohit Loomba; Jessica Liu; Hwai-I Yang; Mei-Hsuan Lee; Sheng-Nan Lu; Li-Yu Wang; Uchenna H Iloeje; San-Lin You; David Brenner; Chien-Jen Chen
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-10       Impact factor: 11.382

4.  Clinical outcomes of patients with acute lymphoblastic leukemia receiving the hyper-CVAD regimen and assessment of the risk of hepatitis flares due to hepatitis B virus reactivation after chemotherapy.

Authors:  Man Fai Law; Hay Nun Chan; Shun Yin Kong; Ho Kei Lai; Chung Yin Ha; Celia Ng; Yiu Ming Yeung; Sze Fai Yip
Journal:  Arch Med Sci       Date:  2021-03-19       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.